As of 2026-09-24, the Relative Valuation of BioXcel Therapeutics Inc (BTAI) is (6.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of BioXcel Therapeutics Inc based on Relative Valuation is -9542.1%.
The range of the Relative Valuation is (6.37) - (7.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.1x - 29.7x | 27.4x |
| Forward P/E multiples | 25.2x - 30.5x | 27.8x |
| Fair Price | (6.37) - (7.50) | (6.98) |
| Upside | -8713.3% - -10251.4% | -9542.1% |
| Date | P/E |
| 2026-09-22 | -0.18 |
| 2026-09-21 | -0.24 |
| 2026-09-18 | -0.23 |
| 2026-09-17 | -0.30 |
| 2026-09-16 | -0.26 |
| 2026-09-15 | -0.18 |
| 2026-09-14 | -0.18 |
| 2026-09-11 | -0.20 |
| 2026-09-10 | -0.20 |
| 2026-09-09 | -0.19 |
| 2026-09-08 | -0.17 |
| 2026-09-04 | -0.29 |
| 2026-09-03 | -0.47 |
| 2026-09-02 | -0.42 |
| 2026-09-01 | -0.54 |
| 2026-08-31 | -0.64 |
| 2026-08-28 | -0.72 |
| 2026-08-27 | -2.85 |
| 2026-08-26 | -3.09 |
| 2026-08-25 | -2.94 |
| 2026-08-24 | -3.01 |
| 2026-08-21 | -3.18 |
| 2026-08-20 | -3.16 |
| 2026-08-19 | -3.28 |
| 2026-08-18 | -3.14 |
| 2026-08-17 | -3.52 |
| 2026-08-14 | -4.71 |
| 2026-08-13 | -4.47 |
| 2026-08-12 | -4.20 |
| 2026-08-11 | -3.69 |
| 2026-08-10 | -3.67 |
| 2026-08-07 | -3.57 |
| 2026-08-06 | -3.29 |
| 2026-08-05 | -3.33 |
| 2026-08-04 | -3.41 |
| 2026-08-03 | -3.36 |
| 2026-07-31 | -3.20 |
| 2026-07-30 | -3.14 |
| 2026-07-29 | -3.18 |
| 2026-07-28 | -3.35 |
| 2026-07-27 | -3.43 |
| 2026-07-24 | -3.36 |
| 2026-07-23 | -3.45 |
| 2026-07-22 | -3.48 |
| 2026-07-21 | -3.55 |
| 2026-07-20 | -3.49 |
| 2026-07-17 | -3.51 |
| 2026-07-16 | -3.44 |
| 2026-07-15 | -3.65 |
| 2026-07-14 | -4.08 |